VISN-wide BPA for point of care whole blood glucose testing equipment and supplies
Ended Awarded Last action
- Contract number
- 36C25622N0142
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 16
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- -$22,138
Award facts
- Contract value 0% obligated
- $22,071.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$22,138 | |
| Original award | $44,209 |
About this award
Roche Diagnostics Corporation received a Blanket Purchase Agreement (BPA) call order valued at $22,071.28 from Veterans Integrated Service Network (VISN) 16 for point-of-care whole blood glucose testing equipment and supplies. The contract was awarded on October 1, 2021, with an ultimate completion date of September 30, 2022, under a firm fixed-price structure with no set-aside designation. This award represents a call against Roche's parent General Services Administration Schedule contract for In Vitro Diagnostics, Reagents, and Test supplies (FSS-65-VII), enabling the Veterans Health Administration facility in Castleton, Indiana, to procure glucose monitoring devices and associated consumables through pre-negotiated pricing terms.
As a leading global supplier of diagnostic solutions, Roche Diagnostics Corporation maintains an extensive portfolio of federal contracts across the Department of Veterans Affairs' multiple VISNs, the Defense Health Administration, and other civilian federal healthcare agencies. The company's comprehensive offering includes point-of-care testing platforms, laboratory analyzers, reagents, and support services tailored to the healthcare delivery needs of military personnel, veterans, and civilian populations. This particular VISN 16 award reflects the ongoing demand for reliable glucose testing capabilities within the Veterans Health Administration's network, supporting diabetes management and chronic disease monitoring for veteran patients.
Quick answers
Who was awarded contract 36C25622N0142?
36C25622N0142 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 16 (Veterans Health Administration) on October 1, 2021.
How much is contract 36C25622N0142 worth?
The government has obligated -$22,138 on 36C25622N0142. Its current value, with exercised options, is $22,071.
Is contract 36C25622N0142 an order under another contract?
Yes. 36C25622N0142 is a BPA call under V797P5279B-36C25621A0023, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25622N0142 competed?
The extent of competition for 36C25622N0142 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award